Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen

Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen

US Patent 6217868 · Granted Apr 17, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody specific for CD22 and methods of use thereof2024
Anti-kit antibodies and uses thereof2024
Anti-MET antibodies and methods of use thereof2024
Humanized antibodies against CEACAM12024
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023
Compositions and methods for immunotherapy2023
Antibodies, uses thereof and conjugates thereof2022
Polynucleotides encoding humanized antibodies against CEACAM12022
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor2022
Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and strok2022
Methods of treating by administering anti-kit antibodies2020
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2020